Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NTLA

Intellia Therapeutics, Inc.

CIK 0001652130 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$12.84
↑ 0.40 (3.22%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.80B
P/E Ratio
-4.50
EPS
-3.81
Dividend Yield
Not covered
52W Position
24%
Beta
2.31

Valuation multiples

Fwd P/E
Not covered
PEG
-0.10
P/B
2.47
P/S
30.24
EV/Revenue
28.45
ROE
-55.0%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 24%
$7.95$28.25

Latest Financials

2025-12-31 FY
Revenue
$67.67M
Net Income
-$412.69M
Total Assets
$842.13M
Free Cash Flow
-$395.87M

Recent news